Primary antiphospholipid syndrome: Pregnancy outcome in a Portuguese population

Acta Reumatologica Portuguesa

Volumn 34, Issue 3, 2009, Pages 492-497

  Serrano, Fatima ^a,c   Nogueira, Isabel ^a   Borges, Augusta ^b   Branco, Jorge ^c  

^a Recurrent miscarriage Clinic   (Portugal)

^b Universidade Nova de Lisboa ^*  (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Aspirin; Low molecular weight heparin; Outcome; Pregnancy; Primary antiphospholipid syndrome

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; FEMALE; HUMAN; PORTUGAL; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RETROSPECTIVE STUDY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; PORTUGAL; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 72449128430     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wilson W, Gharavi A et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International Workshop. Arthritis Rheum 1999; 42:1309-1311.
2. Miyakis S, Lockshin T, Branch D et al. International consensus statment on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 2006; 4: 297.
3. Branch D, Eller A. Antiphospholipid syndrome and thrombosis. Clin Obstet and Gynecol 2006; 49: 861--874.
4. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies. BMJ 1997; 314: 253-257.
5. Bowie E, Thompson J, Pascuzzi C. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430.
6. Greaves M. Pathogenesis and management of antiphospholip syndrome. Thromb Res 2009; 123: 4-9.
7. Nilsson I, Asted B, Hedner U. Intrauterine death and circulating anticoagulant. Acta Med Scand 1975; 197: 153-159.
8. Firkin B, Howard M, Radford N. Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet 1980; 2: 366.
9. Carreras L, Defreyn G, Machin S et al. Arterial thrombosis, intrauterine death and "lupus" anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244-246.
10. Harris E. Syndrome of the black swan. Br J Rheumatol 1987; 26: 324-326.
11. Derksen RH, Khamashta MA, Branch DW. Obstetric antiphospholipid syndrome. Arthritis Rheum 2004; 50: 1028-1039.
12. MackmanN, Girardi G. Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflamatory molecule. Lupus 2008; 17: 931-936.
13. Rai L, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995; 10: 3301-3304.
14. Geis W, Branch W. Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications. Clin Obstet and Gynecol 2001; 44: 2--10.
15. Branch D. Antiphospholipid antibodies and pregnancy maternal implications. Semin Perinatal 1990; 14: 139-146.
16. Esplin M. Management of antiphospholipid syndrome during pregnancy. Clin Obstet Gynecol 2001; 44: 20-28.
17. Branch D, Peacemen A et al. A multicenter, placebocontrolled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obst and Gynec 2000; 182: 122-127.
18. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 2003; 101: 1333-1344.
19. Cervera R and Balasch J. The management of pregnant patients with antiphospholipid syndrome. Lupus 2004; 13: 683-687
20. Lima F, Khamashta M, Buchanan N, Kerslake S, Hunt B, Hughes G. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumat 1996; 14: 131-136.
21. Stone S, Hunt BJ, Khamashta MA, Bewley SJ, Nelson-Piercy C. Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol. J Thromb Haemost 2005; 3: 243-245.
22. Tincani A, Lojacono A, Taglietti M et al. Pregnancy and neonatal outcome in primary antiphospholipid syndrome. Lupus 2002; 11: 649.
23. Branch DW, Andres R, Digre KB, Rote NS, Scott Jr. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73: 541--545.
24. Dreyfus M, Hedelin G, Kutnahorsky R et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet Gynecol 2001; 97: 29-34.
25. Lee R, Brown M, Branch D, Ward K, Silver R. Anticardiolipin and anti B2 glicoprotein I antibodies in preeclampsia. Obstet Gynecol 2003; 102: 294-300.
26. Mello G, Parretti E, Marozio L et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005; 46: 1270-1274.
27. Lermann R, Ribeiro F, Dias E, Campos A. Complicações hipertensivas na gravidez na Maternidade Dr. Alfredo da Costa. Arquivos Mat. Alfredo da Costa 2006; 6: 9-11.
28. Le Thi Thuong et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005; 64: 273--278.
29. Salmon JE, Girardi G, Lockshin MD. The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nat Clin Pract Rheumatol 2007; 3:140-147.
30. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996; 7: 182-188.
31. De Carolis S, Botta A, Garofalo S et al. Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with antiphospholipid syndrome: a review. Ann N Y Acad Sci. Jun 2007; 1108: 530-539.
32. Ruiz-Irastorza G, Khamashta MA. Antiphospholipid syndrome in pregnancy. Rheum Dis Clin North Am 2007; 33: 287-297.
33. Le Thi Thuong D, Wechsler B, Vauthier-Brouzes D et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology 2006; 45: 332-338.
34. Backos M, Rai R, Baxter N, Chilcott I, Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. BJOG 2005; 106: 102-107.